{"nctId":"NCT01900054","briefTitle":"A Long-Term Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis","startDateStruct":{"date":"2013-06"},"conditions":["Perennial Allergic Rhinitis"],"count":58,"armGroups":[{"label":"TAU-284","type":"EXPERIMENTAL","interventionNames":["Drug: Bepotastine besilate"]}],"interventions":[{"name":"Bepotastine besilate","otherNames":["TALION 5mg tablets"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Patients aged between 7 and 15 years\n* Patients who have received a diagnosis of perennial allergic rhinitis according to the diagnostic criteria\n* Patients with a mean total score for the three major nasal symptoms \\[sneezing, rhinorrhea, and nasal congestion\\] of at least 3 on the basis of symptoms recorded in the nasal allergy diary during the observation period etc.\n\nExclusion Criteria:\n\n* Patients with vasomotor rhinitis or eosinophilic rhinitis\n* Patients who have concurrent nasal disease that may affect the efficacy of TAU-284\n* Patients with a history of any of the nasal surgical procedures\n* Patients with current or previous history of drug allergy\n* Patients who concurrently have renal function abnormalities that may cause safety problems etc.","healthyVolunteers":false,"sex":"ALL","minimumAge":"7 Years","maximumAge":"15 Years","stdAges":["CHILD"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Patients With Adverse Events and Adverse Drug Reactions","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"37","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Total Score for the Three Major Nasal Symptoms [Sneezing, Rhinorrhea, and Nasal Congestion] at Week2, Week4, Week6, Week8, Week10, Week 12 and Final Evaluation Point.","description":"Total score for the three major nasal symptoms (sneezing, rhinorrhea, and nasal congestion) were rated on 5-point scale ranging from 0 (no symptom) to 4 (very severe).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.943","spread":"1.549"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.388","spread":"1.465"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.321","spread":"1.844"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.433","spread":"1.880"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.460","spread":"1.777"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.451","spread":"1.707"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.440","spread":"1.678"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Individual Nasal Symptom Scores (Sneezing, Rhinorrhea, Nasal Congestion, and Impairment in Daily Activities)","description":null,"classes":[]},{"type":"SECONDARY","title":"Change From Baseline in Individual Scores for Local Nasal Findings (Rhinoscopic Findings)","description":null,"classes":[]},{"type":"SECONDARY","title":"Change From Baseline in Severity Score for Symptoms of Allergic Rhinitis","description":null,"classes":[]},{"type":"SECONDARY","title":"Influence of Activities in Daily Life(Study, Outing, Sleeping)","description":null,"classes":[]},{"type":"SECONDARY","title":"Patient Impression of Nasal Symptoms(Sneezing, Rhinorrhea, Nasal Congestion, Nasal Pruritus, Eye Pruritus and Eye Tearing)","description":null,"classes":[]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":58},"commonTop":["Nasopharyngitis","Upper respiratory tract inflammation","Otitis externa","Pharyngitis","Epistaxis"]}}}